

Liver hemangioma; Hemangioma of the liver; Cavernous hepatic hemangioma; Infantile hemangioendothelioma; Multinodular hepatic hemangiomatosis
A hepatic hemangioma is the most common noncancerous tumor of the liver. It is believed to be a birth defect, and is usually not discovered until medical pictures are taken of the liver for some other reason.
Hepatic hemangiomas can occur at anytime, but are most common in the 30s to 50s. Women are affected more often than men, and usually have bigger tumors than men.
Babies may develop a type of hepatic hemangioma called benign infantile hemangioendothelioma (also called multinodular hepatic hemangiomatosis). This rare, noncancerous tumor has been linked to high rates of heart failure and death in infants. Infants are usually diagnosed by the time they are 6 months old.
Hemangiomas may cause bleeding or interfere with organ function, depending on their location. Most cavernous hemangiomas do not show symptoms. In rare cases, a cavernous hemangioma may rupture. (The only symptom may be an enlarged liver.)
Babies with benign infantile hemangioendothelioma may have an abdominal mass, anemia, and signs of heart failure.
The following tests may be performed:
Most cavernous hepatic hemangiomas are treated only if there is persistent pain.
Treatment for infantile hemangioendothelioma depends on the child's growth and development. The following treatments may be needed:
In infants whose tumor is only in one lobe of the liver, surgery is a cure, even if the child has heart failure.
Feldman M, Friedman LS, Sleisenger MH, eds. Sleisenger & Fordtran’s Gastrointestinal and Liver Disease. 7th ed. Philadelphia, PA: WB Saunders; 2002:1592-1594.
Zipes DP, Libby P, Bonow RO, Braunwald E, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th ed. St. Louis, Mo; WB Saunders; 2005: 562.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. � 1997- 2008 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.